H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH |
| カタログ番号GA22168 |
CRGDFPASSCは、血小板表面のフィブリノーゲン受容体に結合する環状RGD含有デカペプチドです。このアナログは、位置5のSerがPheに置換されたものであり、血小板凝集阻害剤としてCRGDSPASSCよりも3倍活性が高いことが発見されました（IC?? = 2.5 µM）。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 166184-23-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CRGDFPASSC is a cyclic RGD-containing decapeptide which binds to the fibrinogen receptor on the platelet surface. This analog with Phe substituted for Ser at position 5 was found to be 3 times more active (IC50 = 2.5 µM) as a platelet aggregation i
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *